Murrell, Emily
Narciso, Lucas
Desmond, Kimberly L.
Chow, Caitlin
Lindberg, Anton
Garcia, Armando
Mathis, Chester A.
Svensson, Samuel
Strafella, Antonio P.
Vasdev, Neil https://orcid.org/0000-0002-2087-5125
Funding for this research was provided by:
Tau Consortium (Tau Consortium)
CurePSP (CurePSP)
Michael J. Fox Foundation for Parkinson's Research (MJFF-024347 & MJFF-024348)
Canada Research Chairs (Tier-1)
Ontario Research Foundation (JELF)
Canada Foundation for Innovation (JELF)
Rossy Foundation (Rossy Foundation)
Krembil Foundation (Krembil Foundation)
Azrieli Foundation (Azrieli Foundation)
Canadian Institutes of Health Research (PJT-173540)
Article History
Received: 11 March 2025
Accepted: 6 June 2025
First Online: 24 June 2025
Declarations
:
: This study was approved by the CAMH Research Ethics Board and was conducted in accordance with the Declaration of Helsinki ethical standards.
: Participants provided written informed consent in compliance with the Tri-Council Policy Statement of Ethical Conduct for Research Involving Humans.
: Not applicable.
: S.S. was an employee of Oxiant Discovery during the conduct of the reported study who may own or hold stock options in the company. N.V. is a co-founder of MedChem Imaging, Inc., which did not contribute support for this study. The authors declare no other competing interest.